IL177888A0 - X-ray contrast formulation comprising a mixture of iodinated monomer and dimer - Google Patents

X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Info

Publication number
IL177888A0
IL177888A0 IL177888A IL17788806A IL177888A0 IL 177888 A0 IL177888 A0 IL 177888A0 IL 177888 A IL177888 A IL 177888A IL 17788806 A IL17788806 A IL 17788806A IL 177888 A0 IL177888 A0 IL 177888A0
Authority
IL
Israel
Prior art keywords
mixture
dimer
ray contrast
triiodo
monomer
Prior art date
Application number
IL177888A
Other languages
English (en)
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of IL177888A0 publication Critical patent/IL177888A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL177888A 2004-03-11 2006-09-04 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer IL177888A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55224004P 2004-03-11 2004-03-11
PCT/US2005/008389 WO2005087272A2 (en) 2004-03-11 2005-03-11 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Publications (1)

Publication Number Publication Date
IL177888A0 true IL177888A0 (en) 2006-12-31

Family

ID=34964357

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177888A IL177888A0 (en) 2004-03-11 2006-09-04 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Country Status (12)

Country Link
US (1) US8679460B2 (https=)
EP (2) EP1725268B1 (https=)
JP (1) JP2007528424A (https=)
KR (1) KR20070015517A (https=)
CN (1) CN1938050A (https=)
AT (1) ATE529135T1 (https=)
AU (1) AU2005221716A1 (https=)
CA (1) CA2559628A1 (https=)
ES (1) ES2374633T3 (https=)
IL (1) IL177888A0 (https=)
NO (1) NO20064629L (https=)
WO (1) WO2005087272A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2240432B1 (en) * 2008-01-14 2012-07-04 Mallinckrodt LLC Process for the preparation of iosimenol
US11219696B2 (en) 2008-12-19 2022-01-11 Nationwide Children's Hospital Delivery of polynucleotides using recombinant AAV9
CN102271715A (zh) 2009-01-09 2011-12-07 通用电气医疗集团股份有限公司 对比剂组合物
JP5947784B2 (ja) * 2010-03-23 2016-07-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ 安定化ｘ線診断用組成物の製法
US20130039888A1 (en) 2011-06-08 2013-02-14 Nationwide Children's Hospital Inc. Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
JP2013091701A (ja) 2011-10-25 2013-05-16 Dow Corning Toray Co Ltd 硬化性組成物
US9725716B2 (en) * 2011-12-06 2017-08-08 Ohio State Innovation Foundation and Research Institute at Nationwide Children's Hospital Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
CN104114190A (zh) * 2012-01-11 2014-10-22 通用电气医疗集团股份有限公司 具有低碘浓度的x-射线成像造影介质和x-射线成像方法
WO2013180777A1 (en) * 2012-05-30 2013-12-05 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins
AU2013296425B2 (en) 2012-08-01 2018-06-07 Nationwide Children's Hospital Intrathecal delivery of recombinant adeno-associated virus 9
KR102151088B1 (ko) * 2018-07-10 2020-09-02 한국원자력연구원 소체와 연결된 실 모양의 구조물 가시화 조성물 및 이의 가시화 방법
CN112386712B (zh) * 2020-11-09 2022-08-30 张洪 分子探针及其制备方法和用途
CN119656340A (zh) * 2024-12-13 2025-03-21 福安药业集团宁波天衡制药有限公司 一种碘佛醇注射液及其制备方法
CN120899953B (zh) * 2025-10-13 2025-12-12 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511871A1 (fr) 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants et produits opacifiants ainsi obtenus
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
EP0619744A4 (en) 1991-12-03 1995-02-08 Mallinckrodt Medical Inc NON-ionic X-RAY CONTRASTS, COMPOSITIONS AND METHODS.
IT1256248B (it) 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE19627309C2 (de) 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel
ITMI20011706A1 (it) 2001-08-03 2003-02-03 Bracco Imaging Spa Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
US8518373B2 (en) * 2001-08-03 2013-08-27 Bracco Imaging Spa Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance

Also Published As

Publication number Publication date
ES2374633T3 (es) 2012-02-20
US20080317675A1 (en) 2008-12-25
EP2253332A2 (en) 2010-11-24
US8679460B2 (en) 2014-03-25
EP2253332B1 (en) 2012-10-10
WO2005087272A2 (en) 2005-09-22
EP2253332A3 (en) 2011-03-23
KR20070015517A (ko) 2007-02-05
EP1725268A2 (en) 2006-11-29
AU2005221716A1 (en) 2005-09-22
CN1938050A (zh) 2007-03-28
NO20064629L (no) 2006-11-28
CA2559628A1 (en) 2005-09-22
WO2005087272A3 (en) 2006-06-22
JP2007528424A (ja) 2007-10-11
EP1725268B1 (en) 2011-10-19
ATE529135T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
IL177888A0 (en) X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
WO2009008734A3 (en) Contrast agents
TW200738666A (en) Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
MX2008000141A (es) Moduladores de lxr basados en imidazol.
MX2007012936A (es) Derivados de dihidrobenzofurano y usos de los mismos.
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
GEP20125506B (en) Glucagon receptor antagonist compounds, compositions containing such compounds and use
CL2008001775A1 (es) Compuestos derivados de 2-amino-7-alquinil-[1,8]naftiridona, inhibidores de vegfr-3; composición farmacéutica; combinación farmacéutica; procedimiento de preparación; compuesto intermediario; y uso en el tratamiento del cáncer.
PL396711A1 (pl) Koniugaty polimerów z cytokinami, chemokinami, czynnikami wzrostu, hormonami polipeptydowymi i ich antagonistami, kompozycja farmaceutyczna i sposób zapobiegania, diagnozowania lub leczenia
JP2010175878A5 (https=)
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
DE675738T1 (de) Wässerige Einspritzbare Zusammensetzungen verwendbar zur Radiodiagnose enthaltendenJodierten Aromatischen Verbindungen zur VerwendungalsRöntgenkontrastmittel.
CR11155A (es) Formulaciones solidas de artropodicidas de carboxamida
PA8556901A1 (es) Nuevos derivados de piperazina
AU2003228770A8 (en) Substituted pyrazolopyrimidines
TW200722100A (en) A therapeutic agent for a β related disorders
ECSP077262A (es) Composicion antihistaminica
ATE496881T1 (de) Kontrastmittel
DE60230424D1 (en) Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität
IL198995A0 (en) Novel compound having affinity for amyloid
IL194889A0 (en) Compound having affinity to amyloid
EP3502226A1 (en) Gel composition
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
EP2402321A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
MXPA04005313A (es) Derivados de aminotetralin como antagonistas del receptor muscarinico.